Altimmune, Inc.
ALT
$5.32
$0.214.13%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -19.01M | -22.15M | -19.58M | -23.18M | -22.85M |
| Total Depreciation and Amortization | 27.00K | 30.00K | 29.00K | 33.00K | 37.00K |
| Total Amortization of Deferred Charges | 113.00K | 58.00K | -- | -- | -- |
| Total Other Non-Cash Items | 3.44M | 2.50M | 3.31M | 2.42M | 2.09M |
| Change in Net Operating Assets | 3.53M | 209.00K | -608.00K | 2.46M | -6.40M |
| Cash from Operations | -11.90M | -19.35M | -16.84M | -18.27M | -27.12M |
| Capital Expenditure | 0.00 | -10.00K | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -149.32M | 101.12M | -5.10M | 13.63M | 1.20M |
| Cash from Investing | -149.32M | 101.11M | -5.10M | 13.63M | 1.20M |
| Total Debt Issued | 0.00 | 15.00M | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 39.67M | 37.83M | 34.92M | 10.09M | 270.00K |
| Repurchase of Common Stock | 0.00 | -6.00K | -678.00K | -2.00K | -4.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -322.00K | -577.00K | -125.00K | -- | -- |
| Cash from Financing | 39.35M | 52.24M | 34.12M | 10.09M | 266.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -121.87M | 134.00M | 12.18M | 5.45M | -25.65M |